摘要 |
<p>The present invention provides a compound of the general formula (1): wherein one of X and Y is N and the other is an optionally substituted carbon atom, and Z2-Z5 represent one or two nitrogen atoms, as further described herein, including pharmaceutically acceptable salts, enantiomers, stereoisomers, rotamers, tautomers, diastereomers, or racemates thereof. These compounds inhibit the activity of CDK9 and are thus useful as pharmaceuticals and as components of pharmaceutical compositions. Also provided are methods of treating a disease or condition mediated by CDK9 using the compounds described herein or pharmaceutical compositions comprising such compounds.</p> |
申请人 |
NOVARTIS AG;BARSANTI, PAUL, A.;HU, CHENG;JIN, XIANMING;NG, SIMON, C.;PFISTER, KEITH, B.;SENDZIK, MARTIN;SUTTON, JAMES |
发明人 |
BARSANTI, PAUL, A.;HU, CHENG;JIN, XIANMING;NG, SIMON, C.;PFISTER, KEITH, B.;SENDZIK, MARTIN;SUTTON, JAMES |